To address special needs for small projects Eurofins MWG Operon has expanded its capacity with Roche GS Junior sequencer

Ebersberg, Germany – Eurofins MWG Operon, an expert in next generation sequencing (NGS) has expanded its sequencing capacity with a Roche GS Junior. The GS Junior is the optimum system for the sequencing of smaller scale projects which would require only one eighth of the capacity of a GS FLX Titanium run or which would not be suitable for an Illumina run. As a consequence, the GS Junior adds a higher degree of flexibility in project planning and will have a positive impact on the turn around time for small sized projects. In addition, it allows new possibilities in quality control, e.g. library checking in advance of starting high throughput sequencing or the validation of NGS data for molecular

diagnostics.

“We are pleased to integrate this new system in our NGS service pipeline. It allows our customers to plan experiments that have not been possible in this short timeframe before. In addition, it will secure the high quality of our high throughput sequencing projects and allow us to develop new applications in a reasonable time and at reasonable cost”, says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services. GS FLX Titanium and GS Junior are trademarks of Roche.

About Eurofins MWG Operon

Eurofins MWG Operon, a member of the Eurofins Group with major offices and production facilities in Europe, the United States, and Asia, is an international provider of DNA sequencing services, DNA synthesis products and bioinformatic services for academic and industrial research. As one of the first service providers for next generation sequencing, Eurofins MWG Operon has established profound know-how and proprietary protocols to cover a broad range of applications. The company’s strength is its strong customer orientation, fast service, and high quality. For further information, please visit our website at: www.eurofinsdna.com